Deferasirox Market Analysis by 2025: Novartis, Sun Pharma, Natco Pharma, Cipla
The worldwide market for Deferasirox is expected to grow at a CAGR of roughly 4.7% over the next five years, will reach 2990 million US$ in 2023, from 2270 million US$ in 2017, according to a new Marketexpertz Study.
View full press release